105a LABORATOARELE URGO
First aid and family medication specialists, Urgo is the French market leader in plasters and dressings with the Urgo trademark, and in treatment for colds with Humex, and they are enjoying high growth in wound-healing, in particular thanks to Urgotul.
With a net turnover of 225 million € in 2006 (7% growth), Urgo is asserting its international ambitions: 44% of turnover is achieved outside France, due to its successful presence in more than 80 countries.
It is by proposing innovative and quality products and services entirely dedicated to healthcare that Urgo is pursuing its goal of international development.
The objective of the URGO company is to identify consumer health and health care needs and to provide innovative solutions based on its technological, scientific and marketing know-how.
An entrepreneurial spirit, confidence in one's colleagues, respecting customers and dialogue with share-holders, these are URGO's key values which are the basis of profitable growth in a continuing economically viable and human setting.
Skin care and care of a wound comprise the priority development, in direct cooperation with health care professionals, i.e. pharmacists, physicians, nurses etc.
Based on the URGO brand name support, our company has mobilized its human and financial resources to conquer new markets. The OTC market today continues to be of essential importance in France with strong brand names in the markets for respiratory tract disorders and pain: Humex and Intralgis.
To achieve its objective of development, URGO has to expand its activities internationally, with Europe being a priority, through alliances, acquisitions and the strengthening of the distributor brand name.
|Prima pagina | Piata Pharma | Evenimente | Companii | Joburi | Evolutie | Articole | Utile | Forum | Contact|
|Copyright © 2007: RepMed | Piata Pharma.|